Data-Driven Healthcare: What’s New, What’s Next

Data-Driven Healthcare: What’s New, What’s Next

The amount of data we produce every day is mind-blowing. And, with this avalanche of big data, and the advent of new digital technologies, we can move drug development into the modern era and most importantly, help improve outcomes for patients.

At this year’s Aspen Ideas: Health Festival, I spoke on a panel that discussed, “how big data is changing healthcare.” Here are some examples of what’s already possible and what I would like to see next:

Improve Drug Discovery and Development: Digital technologies have huge potential to make the drug discovery and development process faster, cheaper and more reliable. One area where we’ve seen a lot of success, is the use of real-world data (RWD) to further evaluate the potential of a medicine from “real life” experiences. While randomized clinical trials have been, and continue to be, the “gold standard” framework for understanding the efficacy and safety of therapies, we’ve seen that RWD can play an important role where clinical trials fall short. For example, Pfizer recently used RWD to expand the U.S. indication of one of our therapies in an underserved patient population, where fewer clinical trials are conducted that include these individuals.

But, with big data we can take this practice to the next level. For example, I imagine us using big data to model synthetic control arms for our oncology studies. When enrolling in a clinical trial, participants often fear that they will not receive the new, innovative therapy being tested, and end up receiving the current standard of care. Synthetic control arms offer us the opportunity to ease this concern, helping us enroll even more patients in trials, speed up the process and reduce the cost of drug development. 

Enhance Diagnoses and Quality of Care: We know it can take years until people with certain diseases get the right diagnosis and the right treatment. One of the key areas where big data and artificial intelligence can have an impact is in reducing diagnostic errors. In fact, a recent study conducted by researchers from Google and several medical centers found that computers were just as good, and sometimes better, at detecting tiny lung cancers on CT scans. Of course, the technology is a work in progress and not ready for widespread use. But, the study offers a glimpse of the future of artificial intelligence in medicine and how big data can support doctors in diagnosing their patients and improving outcomes. 

There are still many challenges in the healthcare system that we must overcome to use big data to its fullest potential, but we can look for solutions to better understand each other’s fields and the data at hand.

I’m confident that with continued partnership, big data will empower scientists, physicians, and patients.

Barbara Ruiz Verduzco

Government Affairs Lead at Astellas Farma Mexico

5 年

Loved the “partnership will empower . . .” Team Empowerment in a clinical setting is what makes multidisciplinary decisions obtain the best Oncologic outcome for each individual patient. “Data are just summaries of thousands of stories – tell a few of those stories to help make the data meaningful.” — Chip & Dan Heath.

Osman Daggezen

Pharma Digital Transformation Consultant | Helping Pharma Businesses to Enhance Omnichannel Customer Experience | Author of "Omnichannel Customer Engagement in Pharma" Book | Board Member | Lifelong Learner

5 年

Great article Andy, and for me "Partnership" is the key here to make use of big data for the good of humanity through potential collaborations among all healthcare ecosystem stakeholders.

Peter Prest

Prest Enterprise Solutions

5 年

Andy,? The ability for big data to impact real world patient outcomes is real, but I caution to use of big data to solve all the problems that a patient faces in getting the proper diagnosis, the best treatment plan for their specific cancer, and the ability to coordinate all the other aspects of care.? Oncologists are getting very good at what they are trained and paid to do, treat the cancer.? But what I have seen in my family with cancer is that much is still lost in translation.? My brother quit his ling cancer treatment (non-smoker) and wasted away because the side effects of the cancer treatment were just too much to bear.? Unfortunately, too little was done too late, and many patients just give up and their mindset shifts to a place of no hope.?? Patients needs a road map of what is going to happen, what they need to be committed to for success, and the care givers need to all be aligned with this process.? This is the real world side of patient outcomes.? Let's get big data to capture all that is needed to drive real world outcomes beyond the cancer treatment itself.? Keep up the great work! peter

要查看或添加评论,请登录

Andy Schmeltz的更多文章

  • Key Attributes for Successful Leadership

    Key Attributes for Successful Leadership

    I recently participated in an interview with my MBA alma mater The University of Chicago Booth School of Business where…

    13 条评论
  • The Future is Now: What Gen Z Expects from Us

    The Future is Now: What Gen Z Expects from Us

    As many Gen Zers head off or return to college or graduate school this week (both live and virtually), I’ve been…

    9 条评论
  • Listen, Learn, Act – Our Action Plan for Change

    Listen, Learn, Act – Our Action Plan for Change

    Over the last few months, we’ve been confronted with a serious and real reminder of the racism that persists in our…

    17 条评论
  • Moms Know Best – A Lifetime of Lessons from Two Incredible Women

    Moms Know Best – A Lifetime of Lessons from Two Incredible Women

    I would not be the person I am today without two of the most important women in my life – my mom, Sheila, and my wife…

    23 条评论
  • Be Clear, Kind and Flexible in Times of Uncertainty

    Be Clear, Kind and Flexible in Times of Uncertainty

    In times of crisis when people’s lives are disrupted, the need for leadership is heightened and the role of a leader is…

    42 条评论
  • What I Learned from Friends, Colleagues & Family in 2019

    What I Learned from Friends, Colleagues & Family in 2019

    I have a passion for philosophy. As a kid from a suburb in western Pennsylvania, my world of possibilities exploded…

    24 条评论
  • Protecting My Most Sacred Days

    Protecting My Most Sacred Days

    How do you balance the needs of a business with the needs of the people who enable your success? This question is…

    87 条评论
  • Changing the Story of Cancer: From Loss to Hope

    Changing the Story of Cancer: From Loss to Hope

    Cancer is personal. Almost half of all men and a third of all women in the United States will receive a cancer…

    9 条评论
  • Striving to “Chil-lax to the Max” on Vacation

    Striving to “Chil-lax to the Max” on Vacation

    Too often on family vacations, I’ve been guilty of falling into the “workcation” trap. Checking my phone, answering…

    31 条评论
  • ASCO 2019: Where Do We Go from Here?

    ASCO 2019: Where Do We Go from Here?

    It’s hard to believe the American Society of Clinical Oncology (ASCO) Annual Meeting wrapped up just one week ago. It…

    1 条评论